BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25378531)

  • 1. Till truth makes all things plain: human hearts and stem cells.
    Willerson JT; Taylor D; Perin EC
    Circ Res; 2014 Nov; 115(11):908-10. PubMed ID: 25378531
    [No Abstract]   [Full Text] [Related]  

  • 2. Contemplating the bright future of stem cell therapy for cardiovascular disease.
    Sánchez PL; San Román JA; Villa A; Fernández ME; Fernández-Avilés F
    Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S138-51. PubMed ID: 16501622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial progenitor cells: new hope for a broken heart.
    Szmitko PE; Fedak PW; Weisel RD; Stewart DJ; Kutryk MJ; Verma S
    Circulation; 2003 Jun; 107(24):3093-100. PubMed ID: 12821589
    [No Abstract]   [Full Text] [Related]  

  • 4. Stem cells as future therapy in cardiology.
    Lindsay AC; Halcox JP
    Hosp Med; 2005 Apr; 66(4):215-20. PubMed ID: 15889869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ponzo effect: endothelial progenitor cells appear on the horizon.
    Patterson C
    Circulation; 2003 Jun; 107(24):2995-7. PubMed ID: 12821584
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiac Stem Cell Therapy. Need for Optimization of Efficacy and Safety Monitoring.
    Oettgen P; Boyle AJ; Schulman SP; Hare JM
    Circulation; 2006 Jul; 114(4):353-8. PubMed ID: 16864740
    [No Abstract]   [Full Text] [Related]  

  • 7. Early translation of adipose-derived cell therapy for cardiovascular disease.
    Sanz-Ruiz R; Fernández-Santos E; Domínguez-Muñoa M; Parma R; Villa A; Fernández L; Sánchez PL; Fernández-Avilés F
    Cell Transplant; 2009; 18(3):245-54. PubMed ID: 19558773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cells for myocardial repair and regeneration: where are we today?
    Lee RJ
    Methods Mol Biol; 2010; 660():1-6. PubMed ID: 20680809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trans-coronary transplantation may be an optimal route in cellular cardiomyoplasty with stem cells.
    Li ZZ; Bai SG; Huang J; Qian HY
    Med Hypotheses; 2007; 69(6):1212-8. PubMed ID: 17555882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cell transplant and regenerative therapy with stem cells].
    Prósper F; Gavira JJ; Herreros J; Rábago G; Luquin R; Moreno J; Robles JE; Redondo P
    An Sist Sanit Navar; 2006; 29 Suppl 2():219-34. PubMed ID: 16998528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell therapy after myocardial infarction: ready for clinical application?
    Engelmann MG; Franz WM
    Curr Opin Mol Ther; 2006 Oct; 8(5):396-414. PubMed ID: 17078382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms and stem cell therapy.
    Maisch B
    Herz; 2002 Nov; 27(7):567-9. PubMed ID: 12526145
    [No Abstract]   [Full Text] [Related]  

  • 13. [A new philosophy on stem cell trials in cardiovascular diseases: to collect pollen or to be a beekeeper].
    Alat I
    Anadolu Kardiyol Derg; 2005 Jun; 5(2):150. PubMed ID: 15939697
    [No Abstract]   [Full Text] [Related]  

  • 14. Other approaches to fighting cardiovascular disease: stem cells and engineered tissue.
    Mason C
    Med Device Technol; 2006; 17(1):26-7. PubMed ID: 16483108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials in stem cell therapy: pitfalls and lessons for the future.
    Metharom P; Doyle B; Caplice NM
    Nat Clin Pract Cardiovasc Med; 2007 Feb; 4 Suppl 1():S96-9. PubMed ID: 17230223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential of stem cells in the treatment of cardiovascular diseases.
    Bernal A; Gálvez BG
    Stem Cell Rev Rep; 2013 Dec; 9(6):814-32. PubMed ID: 23949886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cells in cardiovascular disease: methods and protocols.
    Penn MS; Mal N
    Methods Mol Med; 2006; 129():329-51. PubMed ID: 17085822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial progenitor cells: implications for cardiovascular disease.
    Möbius-Winkler S; Höllriegel R; Schuler G; Adams V
    Cytometry A; 2009 Jan; 75(1):25-37. PubMed ID: 19009636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The proarrhythmic risk of cell therapy for cardiovascular diseases.
    Liu Y; Tse HF
    Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1593-601. PubMed ID: 22103878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physiological and cytological bases of cellular regulation of angiogenesis].
    Poveshchenko OV; Poveshchenko AF; Konenkov VI
    Usp Fiziol Nauk; 2012; 43(3):48-61. PubMed ID: 23101379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.